Cargando…

Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2)

BACKGROUND: The high burden of healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) is partially due to excessive antimicrobial use both in human and animal medicine worldwide. How can technology help to overcome challenges in infection prevention and control (IPC) and to preve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zingg, Walter, Park, Benjamin J., Storr, Julie, Ahmad, Raheelah, Tarrant, Carolyn, Castro-Sanchez, Enrique, Perencevich, Eli, Widmer, Andreas, Krause, Karl-Heinz, Kilpatrick, Claire, Tomczyk, Sara, Allegranzi, Benedetta, Cardo, Denise, Pittet, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530187/
https://www.ncbi.nlm.nih.gov/pubmed/31139366
http://dx.doi.org/10.1186/s13756-019-0538-y
_version_ 1783420576310755328
author Zingg, Walter
Park, Benjamin J.
Storr, Julie
Ahmad, Raheelah
Tarrant, Carolyn
Castro-Sanchez, Enrique
Perencevich, Eli
Widmer, Andreas
Krause, Karl-Heinz
Kilpatrick, Claire
Tomczyk, Sara
Allegranzi, Benedetta
Cardo, Denise
Pittet, Didier
author_facet Zingg, Walter
Park, Benjamin J.
Storr, Julie
Ahmad, Raheelah
Tarrant, Carolyn
Castro-Sanchez, Enrique
Perencevich, Eli
Widmer, Andreas
Krause, Karl-Heinz
Kilpatrick, Claire
Tomczyk, Sara
Allegranzi, Benedetta
Cardo, Denise
Pittet, Didier
author_sort Zingg, Walter
collection PubMed
description BACKGROUND: The high burden of healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) is partially due to excessive antimicrobial use both in human and animal medicine worldwide. How can technology help to overcome challenges in infection prevention and control (IPC) and to prevent HAI and emerging AMR? METHODS: In June 2017, 42 international experts convened in Geneva, Switzerland to discuss four potential domains of technology in IPC and AMR: 1) role and potential contribution of microbiome research; 2) whole genome sequencing; 3) effectiveness and benefit of antimicrobial environmental surfaces; and 4) future research in hand hygiene. RESULTS: Research on the microbiome could expand understanding of antimicrobial use and also the role of probiotics or even faecal transplantation for therapeutic purposes. Whole genome sequencing will provide new insights in modes of transmission of infectious diseases. Although it is a powerful tool for public health epidemiology, some challenges with interpretation and costs still need to be addressed. The effectiveness and cost-effectiveness of antimicrobially coated or treated environmental high-touch surfaces requires further research before they can be recommended for routine use. Hand hygiene implementation can be advanced, where technological enhancement of surveillance, technique and compliance are coupled with reminders for healthcare professionals. CONCLUSIONS: The four domains of technological innovation contribute to the prevention of HAI and AMR at different levels. Microbiome research may offer innovative concepts for future prevention, whole genome sequencing could detect new modes of transmission and become an additional tool for effective public health epidemiology, antimicrobial surfaces might help to decrease the environment as source of transmission but continue to raise more questions than answers, and technological innovation may have a role in improving surveillance approaches and supporting best practice in hand hygiene.
format Online
Article
Text
id pubmed-6530187
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65301872019-05-28 Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2) Zingg, Walter Park, Benjamin J. Storr, Julie Ahmad, Raheelah Tarrant, Carolyn Castro-Sanchez, Enrique Perencevich, Eli Widmer, Andreas Krause, Karl-Heinz Kilpatrick, Claire Tomczyk, Sara Allegranzi, Benedetta Cardo, Denise Pittet, Didier Antimicrob Resist Infect Control Research BACKGROUND: The high burden of healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) is partially due to excessive antimicrobial use both in human and animal medicine worldwide. How can technology help to overcome challenges in infection prevention and control (IPC) and to prevent HAI and emerging AMR? METHODS: In June 2017, 42 international experts convened in Geneva, Switzerland to discuss four potential domains of technology in IPC and AMR: 1) role and potential contribution of microbiome research; 2) whole genome sequencing; 3) effectiveness and benefit of antimicrobial environmental surfaces; and 4) future research in hand hygiene. RESULTS: Research on the microbiome could expand understanding of antimicrobial use and also the role of probiotics or even faecal transplantation for therapeutic purposes. Whole genome sequencing will provide new insights in modes of transmission of infectious diseases. Although it is a powerful tool for public health epidemiology, some challenges with interpretation and costs still need to be addressed. The effectiveness and cost-effectiveness of antimicrobially coated or treated environmental high-touch surfaces requires further research before they can be recommended for routine use. Hand hygiene implementation can be advanced, where technological enhancement of surveillance, technique and compliance are coupled with reminders for healthcare professionals. CONCLUSIONS: The four domains of technological innovation contribute to the prevention of HAI and AMR at different levels. Microbiome research may offer innovative concepts for future prevention, whole genome sequencing could detect new modes of transmission and become an additional tool for effective public health epidemiology, antimicrobial surfaces might help to decrease the environment as source of transmission but continue to raise more questions than answers, and technological innovation may have a role in improving surveillance approaches and supporting best practice in hand hygiene. BioMed Central 2019-05-22 /pmc/articles/PMC6530187/ /pubmed/31139366 http://dx.doi.org/10.1186/s13756-019-0538-y Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zingg, Walter
Park, Benjamin J.
Storr, Julie
Ahmad, Raheelah
Tarrant, Carolyn
Castro-Sanchez, Enrique
Perencevich, Eli
Widmer, Andreas
Krause, Karl-Heinz
Kilpatrick, Claire
Tomczyk, Sara
Allegranzi, Benedetta
Cardo, Denise
Pittet, Didier
Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2)
title Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2)
title_full Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2)
title_fullStr Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2)
title_full_unstemmed Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2)
title_short Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2)
title_sort technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 geneva ipc-think tank (part 2)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530187/
https://www.ncbi.nlm.nih.gov/pubmed/31139366
http://dx.doi.org/10.1186/s13756-019-0538-y
work_keys_str_mv AT zinggwalter technologyforthepreventionofantimicrobialresistanceandhealthcareassociatedinfections2017genevaipcthinktankpart2
AT parkbenjaminj technologyforthepreventionofantimicrobialresistanceandhealthcareassociatedinfections2017genevaipcthinktankpart2
AT storrjulie technologyforthepreventionofantimicrobialresistanceandhealthcareassociatedinfections2017genevaipcthinktankpart2
AT ahmadraheelah technologyforthepreventionofantimicrobialresistanceandhealthcareassociatedinfections2017genevaipcthinktankpart2
AT tarrantcarolyn technologyforthepreventionofantimicrobialresistanceandhealthcareassociatedinfections2017genevaipcthinktankpart2
AT castrosanchezenrique technologyforthepreventionofantimicrobialresistanceandhealthcareassociatedinfections2017genevaipcthinktankpart2
AT perencevicheli technologyforthepreventionofantimicrobialresistanceandhealthcareassociatedinfections2017genevaipcthinktankpart2
AT widmerandreas technologyforthepreventionofantimicrobialresistanceandhealthcareassociatedinfections2017genevaipcthinktankpart2
AT krausekarlheinz technologyforthepreventionofantimicrobialresistanceandhealthcareassociatedinfections2017genevaipcthinktankpart2
AT kilpatrickclaire technologyforthepreventionofantimicrobialresistanceandhealthcareassociatedinfections2017genevaipcthinktankpart2
AT tomczyksara technologyforthepreventionofantimicrobialresistanceandhealthcareassociatedinfections2017genevaipcthinktankpart2
AT allegranzibenedetta technologyforthepreventionofantimicrobialresistanceandhealthcareassociatedinfections2017genevaipcthinktankpart2
AT cardodenise technologyforthepreventionofantimicrobialresistanceandhealthcareassociatedinfections2017genevaipcthinktankpart2
AT pittetdidier technologyforthepreventionofantimicrobialresistanceandhealthcareassociatedinfections2017genevaipcthinktankpart2
AT technologyforthepreventionofantimicrobialresistanceandhealthcareassociatedinfections2017genevaipcthinktankpart2